Glow Blend (GHK-CU/BPC157/TB500) 70mg

GLOW Blend (GHK-Cu + BPC157 + TB500) Research Peptide

The GLOW Blend is a multi-component peptide research formulation consisting of three distinct bioactive compounds: GHK-Cu (a copper-chelated tripeptide), BPC157 (a 15-amino-acid synthetic peptide), and TB500 (beta-4 thymosin). By combining these three agents, researchers can investigate both independent and potentially synergistic mechanisms across shared biological pathways associated with tissue integrity, extracellular remodeling, and cellular resilience.

GHK-Cu operates as a copper-coordinated complex that engages with collagen biosynthesis, matrix metalloproteinase regulation, and growth factor signaling networks, with documented effects on fibroblast proliferation and extracellular matrix deposition in dermal and subcutaneous tissue models. BPC157 exhibits a broad range of biological activity, encompassing modulation of nitric oxide production, growth hormone release signaling, and vascular endothelial function. TB500 (beta-4 thymosin) is an actin-binding peptide implicated in cytoskeletal organization and the regulation of cellular migration.

The combination of all three compounds provides a platform for exploring whether concurrent targeting of collagen homeostasis via GHK-Cu, vascular signaling via BPC157, and cellular motility via TB500 yields additive or synergistic outcomes in preclinical tissue repair models. While the mechanistic groundwork for each individual component is well-supported in published literature — including Pickart et al. (1980), Sikiric et al. (2019), and Goldstein et al. (2005) — research into coordinated multi-peptide protocols remains sparse, lending this blend particular value for exploratory study designs.

GLOW Blend — Product Specifications

• Form: Lyophilized blend

• Composition: GHK-Cu (5mg), BPC157 (2.5mg), TB500 (2.5mg) per vial

• Total Content: 10mg per vial

• Reconstitution: Bacteriostatic water or saline solution (2–4mL per research protocol)

• Storage: 2–8°C in a sealed, moisture-protected container

• Purity: ≥95% for each component, verified by HPLC analysis

• Post-Reconstitution Stability: 72 hours at 4°C

Research Use Only

This formulation is intended solely for in vitro and preclinical research purposes. It has not been approved for human use, therapeutic investigation, or systemic administration outside of regulated research facility environments.